🇺🇸 Trevi Therapeutics, Inc.
Forum topic · TRVI · Company page: financials, ownership and filings
Join the discussion on Trevi Therapeutics, Inc.
Loading…
Results announced on 9 November 2026
Trevi Therapeutics, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $21 million.
Mutual funds: 151 funds hold $646 million
151 mutual funds in 1 country hold shares of Trevi Therapeutics, Inc. worth $646 million, about 26.1% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 95 funds added shares and 36 sold; on balance they bought $85 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.